Bacterial vaginosis vs yeast infection
Pro Research Analysisby 
Searched over 200M research papers
Bacterial Vaginosis vs. Yeast Infection: A Comparative Overview
Prevalence and Co-occurrence
Bacterial Vaginosis Prevalence
Bacterial vaginosis (BV) is a common vaginal infection, affecting approximately one-third of women globally at various life stages4. In a study conducted in a southeastern American STD clinic, BV was diagnosed in 72.5% of female participants1.
Yeast Infection Prevalence
Vulvovaginal candidiasis (VVC), commonly known as a yeast infection, affects 75% of women at least once in their lifetime2. In the same study mentioned above, VVC was observed in 15.7% of participants, regardless of their BV status1.
Mixed Infections
Mixed infections of BV and VVC are not uncommon. Among women diagnosed with BV, 33.1% were also colonized with yeast, leading to a mixed infection prevalence of 4.4%1.
Symptoms and Diagnosis
Symptoms of Bacterial Vaginosis
BV is characterized by abnormal vaginal discharge with a fishy odor, which is a result of an imbalance in the vaginal microbiota4. The diagnosis of BV can be made using clinical criteria (Amsel's criteria) or laboratory methods (Gram stain with objective scoring)2.
Symptoms of Yeast Infection
Yeast infections typically present with itching, redness, and a thick, white discharge resembling cottage cheese. These symptoms are due to the overgrowth of Candida species in the vaginal area2.
Treatment and Management
Treatment of Bacterial Vaginosis
Standard treatment for BV includes oral metronidazole or vaginal metronidazole gel, and clindamycin cream. However, treatment failure and recurrence rates are high, prompting the exploration of alternative treatments such as probiotics and vaginal microbiota transplants2 4.
Treatment of Yeast Infection
VVC is commonly treated with topical and oral antifungal azole medications, which are equally effective. For recurrent VVC, defined as four or more episodes per year, maintenance therapy with weekly oral fluconazole for up to six months is recommended2.
Emerging Treatments
Probiotics
Recent research has focused on the use of Saccharomyces cerevisiae-based probiotics as novel antimicrobial agents to prevent and treat vaginal infections. These probiotics aim to restore the natural balance of the vaginal microbiota, potentially reducing the recurrence of both BV and VVC3 4.
Vaginal Microbiota Transplants
Another innovative approach under investigation is vaginal microbiota transplants. This method involves transplanting healthy vaginal microbiota to restore balance and prevent the overgrowth of pathogenic microbes, offering a promising alternative for women with recurrent BV4.
Conclusion
Bacterial vaginosis and yeast infections are prevalent conditions that significantly impact women's health. While traditional treatments are available, high recurrence rates necessitate the exploration of alternative therapies such as probiotics and vaginal microbiota transplants. Understanding the prevalence, symptoms, and treatment options for these infections can help in better managing and preventing their occurrence.
Sources and full results
Most relevant research papers on this topic
Prevalence of bacterial vaginosis and vulvovaginal candidiasis mixed infection in a southeastern american STD clinic.
The prevalence of bacterial vaginosis/vulvovaginal candidiasis mixed infections in young women is 4.4%, with a higher prevalence in those with BV and lower in those with vulvovaginal candidiasis.
Observational StudyVulvovaginitis: screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis.
Vulvovaginal candidiasis can be effectively managed with topical and oral antifungal azole medications, with partner treatment enhancing cure rates for trichomoniasis.
Systematic Review
Highly CitedSaccharomyces cerevisiae-Based Probiotics as Novel Antimicrobial Agents to Prevent and Treat Vaginal Infections
Yeast-based probiotics show potential as a novel antimicrobial agent for preventing and treating common vaginal infections like vulvovaginal candidiasis and bacterial vaginosis.
Finding a Balance in the Vaginal Microbiome: How Do We Treat and Prevent the Occurrence of Bacterial Vaginosis?
Probiotics and vaginal microbiota transplants show potential in restoring vaginal health and preventing bacterial vaginosis recurrence, with high treatment failure and recurrence rates despite standard antibiotic treatment.
Literature ReviewClinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis.
Probiotic Lactobacillus GR-1 and RC-14 effectively (90%) cure bacterial vaginosis in black women compared to metronidazole treatment, offering a self-use therapy for urogenital infections.
RCTHighly CitedBacterial Vaginosis-Vaginal Polymicrobial Biofilms and Dysbiosis.
Bacterial vaginosis is a complex disease with a focus on vaginal biofilms, requiring new molecular genetic testing methods and therapeutic agents effective against biofilms for effective treatment.
Systematic ReviewAntibiotics for treating bacterial vaginosis in pregnancy.
Antibiotic treatment effectively eradicates bacterial vaginosis during pregnancy and reduces the risk of late miscarriage, but does not reduce the risk of preterm birth before 37 weeks' gestation or preterm prelabour rupture of membranes.
Meta-Analysis
Very Rigorous JournalHighly CitedInfluence of Biofilm Formation by Gardnerella vaginalis and Other Anaerobes on Bacterial Vaginosis.
Biofilm formation by Gardnerella vaginalis and other anaerobes plays a key role in the pathogenesis of bacterial vaginosis, with commensal and synergic interactions between them playing a role in bacterial vaginosis establishment.
Rigorous JournalHighly CitedBacterial Vaginosis Biofilms: Challenges to Current Therapies and Emerging Solutions
Current antibiotics for bacterial vaginosis are insufficient to fully eradicate the vaginal biofilm, leading to high recurrence rates and potential negative impacts on healthy vaginal microflora.
Highly CitedBacterial Vaginosis and Its Association with Infertility, Endometritis, and Pelvic Inflammatory Disease.
Bacterial vaginosis, endometritis, and pelvic inflammatory disease are linked to infertility, and diagnosis and treatment before conception may improve outcomes in natural and assisted reproduction.
Rigorous JournalHighly Cited